7Ikehara. M, Oshita F, Kameda Y, et al. Expression of surviving. Correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung [J]. Cancer Rep, 2002, 9 (4): 835.
2[1]Zaffaroni N, Daidone MG. Survivin expression and resistance to anticancer treatments: Perspectives for new therapeutic interventions [J]. Drug Resist Updat, 2002;5(2):65-72.
3[2]Ikeguchi M, Yamaguchi K, Kaibara N. Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer [J]. Tumour Biol, 2003;24(1):40-45.
4[3]Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer [J]. Br J Cancer, 2003;88(7):1077-1083.
5[4]Xia C, Xu Z, Yuan X, et al. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides [J]. Mol Cancer Ther, 2002;1(9):687-694.
6[5]Marusawa H, Matsuzawa S, Welsh K, et al. HBXIP functions as a cofactor of survivin in apoptosis suppression [J]. EMBO J, 2003;22(11):2729-2740.
7[6]Shen C, Buck A, Polat B, et al. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells [J]. Cancer Gene Ther, 2003;10(5):403-410.
8[7]Kania J, Konturek SJ, Marlicz K, et al. Expression of survivin and caspase-3 in gastric cancer [J]. Dig Dis Sci, 2003;48(2):266-271.
9[8]Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma [J]. Cancer, 2002;95(9):1938-1945.
10[9]Asanuma K, Kobayashi D, Furuya D, et al. A role for survivin in radioresistance of pancreatic cancer cells [J]. Jpn J Cancer Res, 2002;93(9):1057-1062.
3Jemal A,Murray T,Ward E,et al.Cancer stastistics 2005[J].CA Cancer J Clin,2005,55(1):10.
4D britz J,Preston R,H nfler J,et al.Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer:correlation withclinical features and carbohydrate antigen 19-9[J].Pancreas,2009,38(5):534.
5Lee SH,Lee SJ,Chung JY,et al.secreted by K-RasSnail pathway,is endocytosed by K-Ras-mutated cells;implication of target-specific drug delivery and early diagnostic marker[J].Oncogene,2009,28(19):2005.
6Lee SH,Lee SJ,Jung YS,et al.Blocking of p53-Snail binding,promoted by oncogenic K-Ras,recovers p53 expression and function[J].Neoplasia,2009,11(1):22.
7Pogue-Geile KL,Chen R,,Bronner MP,et al.Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism[J].PLo S Med,2006,3(12):e516.
9Buchholz M,Schatz A,Wagner M,et al.Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway[J].EMBO J,2006,25(15):3714.
10Kumari A,Srinivasan R,Wig JD.Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreaticcancer-derived cell lines[J].Pancreatology,2009,9(4):360.
